Raymond James Financial Services Advisors’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.05M Buy
760,457
+78,895
+12% +$713K 0.01% 1126
2024
Q2
$5.72M Buy
681,562
+56,097
+9% +$452K 0.01% 1100
2024
Q1
$5.34M Buy
625,465
+2,913
+0.5% +$24.3K 0.01% 1100
2023
Q4
$5.29M Buy
622,552
+71,845
+13% +$682K 0.01% 1059
2023
Q3
$5.62M Sell
550,707
-30,529
-5% -$317K 0.01% 953
2023
Q2
$7.56M Buy
581,236
+68,533
+13% +$850K 0.01% 826
2023
Q1
$4.76M Buy
512,703
+194,893
+61% +$2.26M 0.01% 1024
2022
Q4
$3.46M Buy
317,810
+280,832
+759% +$1.53M 0.01% 1152
2022
Q3
$149K Sell
36,978
-267
-0.7% -$1.8K ﹤0.01% 2927
2022
Q2
$272K Sell
37,245
-9,666
-21% -$76.4K ﹤0.01% 2664
2022
Q1
$422K Buy
46,911
+8,282
+21% +$79.8K ﹤0.01% 2477
2021
Q4
$436K Sell
38,629
-33,586
-47% -$419K ﹤0.01% 2466
2021
Q3
$1.05M Buy
72,215
+12,053
+20% +$184K ﹤0.01% 1919
2021
Q2
$980K Sell
60,162
-194
-0.3% -$3.61K ﹤0.01% 1954
2021
Q1
$1.21M Buy
60,356
+3,400
+6% +$81.5K ﹤0.01% 1713
2020
Q4
$1.17M Buy
56,956
+14,258
+33% +$262K ﹤0.01% 1608
2020
Q3
$751K Buy
42,698
+31,365
+277% +$498K ﹤0.01% 1727
2020
Q2
$192K Sell
11,333
-4,023
-26% -$50.8K ﹤0.01% 2513
2020
Q1
$148K Buy
+15,356
New +$199K ﹤0.01% 2156

Other funds holding PROF

Raymond James Financial Services Advisors's PROF Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Profound Medical (PROF) stake by 12% in Q3 2024, buying an estimated $713K and bringing the position to 760,457 shares worth $6.05M. The position accounts for 0.01% of the portfolio, ranked #1126.

Raymond James Financial Services Advisors first reported a position in PROF in Q1 2020 and has held it in 19 quarters since. The position peaked at $7.56M in Q2 2023. 44 funds tracked by Wall St. Rank hold PROF as of Q3 2024.

  • Raymond James Financial Services Advisors held 760,457 shares of Profound Medical worth $6.05M as of Q3 2024.
  • Raymond James Financial Services Advisors bought 78,895 Profound Medical shares in Q3 2024, an estimated $713K.
  • Profound Medical made up 0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1126 holding.
  • Raymond James Financial Services Advisors first reported a position in Profound Medical in Q1 2020 and has held it in 19 quarters since.
  • Raymond James Financial Services Advisors's Profound Medical position peaked at $7.56M in Q2 2023.
  • 44 funds tracked by Wall St. Rank held Profound Medical as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.